NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-093-1996-2-US-01 O2-GLYCOSYLATED DIAZENIUMDIOLATES AS NITRIC OXIDE (NO)-RELEASING PRODRUGS US 60/051,696 Abandoned
NCI E-067-1997-0-US-01 COMPOUNDS FORMED BY THE REACTION OF NITRIC OXIDE WITH AMIDINES AND ENAMINES AS PHARMACEUTICAL AGENTS US 60/051,690 Abandoned
NHLBI E-067-1996-0-CA-25 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD CA National Stage 2259465 Abandoned
NHLBI E-067-1996-0-AU-22 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD AU National Stage 36441/97 Abandoned
NHLBI E-067-1996-0-AT-18 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD AT EP 97933194.9 Abandoned
NHLBI E-067-1996-0-BE-10 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD BE EP 97933194.9 Abandoned
NHLBI E-067-1996-0-DK-04 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD DK EP 97933194.9 Abandoned
NHLBI E-067-1996-0-FI-11 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD FI EP 97933194.9 Abandoned
NHLBI E-067-1996-0-MC-16 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD MC EP 97933194.9 Abandoned
NHLBI E-067-1996-0-LI-12 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD LI EP 97933194.9 Abandoned
NHLBI E-067-1996-0-LU-13 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD LU EP 97933194.9 Abandoned
NHLBI E-067-1996-0-NL-05 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD NL EP 97933194.9 Abandoned
NHLBI E-067-1996-0-GB-03 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD GB EP 97933194.9 Abandoned
NHLBI E-067-1996-0-IT-09 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD IT EP 97933194.9 Abandoned
NHLBI E-067-1996-0-IE-15 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD IE EP 97933194.9 Abandoned
NHLBI E-067-1996-0-EP-23 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD EP National Stage 97933194.9 Abandoned
NHLBI E-067-1996-0-PT-17 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD PT EP 97933194.9 Abandoned
NHLBI E-067-1996-0-SE-21 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD SE EP 97933194.9 Abandoned
NHLBI E-067-1996-0-CH-19 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD CH EP 97933194.9 Abandoned
NHLBI E-067-1996-0-ES-20 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD ES EP 97933194.9 Abandoned
NHLBI E-067-1996-0-DE-07 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD DE EP 97933194.9 Abandoned
NHLBI E-067-1996-0-FR-08 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD FR EP 97933194.9 Abandoned
NHLBI E-067-1996-0-GR-14 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD GR EP 97933194.9 Abandoned
NHLBI E-067-1996-0-PCT-02 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD PCT PCT PCT/US1997/011272 Expired
NIAID E-161-1997-0-US-01 Methods of Inactivating Enveloped RNA Virus Particles and Compositions for Use Thereof US 60/052,986 Abandoned
NHLBI E-067-1996-0-JP-24 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD JP National Stage 504341/98 Abandoned
NIDDK E-149-1997-0-US-02 USING CARDIAC PHASE TO ORDER RECONSTRUCTION (CAPTOR) IN MRI US ORD 08/886,487 5997883 Abandoned PDF
NCI E-091-1999-0-CA-04 Identification of a Transforming Fragment of Herpes Simplex Type 2 and Detection Thereof in Clinical Specimens CA National Stage 2259657 Abandoned
NCI E-052-1995-1-US-01 METHOD FOR INDUCING MONOCYTES TO EXHIBIT THE PHENOTYPE OF ACTIVATED MYELOID DENDRITIC CELLS US CIP 08/885,671 6010905 Abandoned PDF
NCI E-091-1999-0-PCT-02 Identification of a Transforming Fragment of Herpes Simplex Type 2 and Detection Thereof in Clinical Specimens PCT PCT PCT/CA1997/000470 Expired
NCI E-216-1997-0-US-01 SPECTRAL CLONING-AN INNOVATIVE TECHNICAL AND CONCEPTUAL APPROACH TO THE CLONING AND CHARACTERIZATION OF EVERY CHROMOSOMAL ABBERRATION ... US 60/051,257 Abandoned
NIDDK E-153-1994-0-NZ-15 METHOD OF TREATING CHRONIC PROGRESSIVE VASCULAR DISEASES NZ National Stage 309991 Abandoned
NIBIB E-071-1997-0-US-01 Method Utilizing Convex Geometry For Laser Capture Microdissection US ORD 08/883,821 6100051 Abandoned PDF
NIDDK E-104-1997-0-NZ-11 METHOD OF TREATING CHRONIC PROGRESSIVE VASCULAR DISEASES NZ ORD 309991 Abandoned
NINDS E-050-1996-0-PCT-02 METHOD OF TREATING AND PREVENTING VASOSPASM PCT PCT PCT/US97/011027 Abandoned
NHGRI E-190-1997-0-US-01 CLONING OF A GENE MUTATION FOR PARKINSON'S DISEASE US 60/050,684 Abandoned
NIDCR E-177-1996-0-US-01 SERUM FREE CELL GROWTH MEDIUM US 60/050,691 Abandoned
NCI E-035-1994-2-US-02 ISOLATION OF CELLULAR MATERIAL UNDER MICROSCOPIC VISUALIZATION US DIV 08/882,699 Abandoned
NCI E-232-1995-1-US-01 Methods of Identifying Patients Having an Altered Immune Status US DIV 08/880,671 5965366 Expired PDF
NCI E-160-1997-1-US-01 PURIFICATION AND MOLECULAR CLONING OF A SECRETED, FRIZZLED-RELATED ANTAGONIST OF WNT ACTION (FRP) US 60/050,495 Abandoned
NIA E-213-1997-0-US-01 A NOVEL ADIPOSE SEVEN TRANSMEMBRANE DOMAIN PROTEIN US 60/050,170 Abandoned
NIMH E-110-1993-0-US-09 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM US DIV 08/879,139 Abandoned
NCI E-124-1996-0-PCT-02 FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE I (FRAG1), RELATED PROTEINS AND METHODS PCT PCT PCT/US1997/010660 Abandoned
NIMH E-012-1991-5-US-03 METHOD OF INDUCING IMMUNE TOLERANCE USING IMMUNOTOXINS US CON 08/878,378 Abandoned
NHGRI E-018-1997-0-US-01 AIB1, A NOVEL STEROID RECEPTOR CO-ACTIVATOR AMPLIFIED IN BREAST CANCER US 60/049,728 Abandoned
NCI E-014-1991-0-US-07 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING SKIN TUMOR FORMATION AND CAUSING REGRESSION OF EXISTING TUMORS US CON 08/876,510 Abandoned
NCI E-136-1990-0-US-23 TREATED BIRDSEED PREFERENTIALLY PALATABLE TO BIRDS BUT NOT PALATABLE TO ANIMALS HAVING CAPSAICIN SENSITIVE RECEPTORS US DIV 08/874,082 5879696 Expired PDF
NCI E-019-1994-1-US-02 Methods and Compositions for Stimulating and Inhibiting TGF-B Activity with regulatory US CON 08/871,561 6384189 Abandoned PDF
NIAID E-188-1997-0-US-01 ENTERICALLY ADMINISTERED RECOMBINANT POXVIRUS VACCINES US ORD 08/485,229 5676950 Expired PDF
NCI E-226-1993-0-US-08 TREATMENT OF CANCER WITH HUMAN CHORIONIC GONADOTROPIN US DIV 08/869,603 5877148 Expired PDF